ORIGINAL ARTICLE
Effect on health-related quality of life of ongoing feedback during
a 12-month maintenance walking programme in patients with
COPD: a randomized controlled trial
SALLYL.WOOTTON,1,2 ZOEMCKEOUGH,1CINDYL.W.NG,3,10SUEJENKINS,3,4,5KYLIEHILL,3,5
PETERR.EASTWOOD,3,6,7DAVIDHILLMAN,6CHRISTINEJENKINS,8NOLACECINS,5LISSASPENCER9AND
JENNIFERALISON1,9
1DisciplineofPhysiotherapy,TheUniversityofSydney,Sydney,NSW;2ChronicDiseaseCommunityRehabilitationService,
NorthernSydneyLocalHealthDistrict,Sydney,NSW;3SchoolofPhysiotherapyandExerciseScience,FacultyofHealth
Sciences,CurtinUniversity,Perth,WA;4PhysiotherapyDepartment,SirCharlesGairdnerHospital,Perth,WA;5Institutefor
RespiratoryHealth,Perth,WA;6DepartmentofPulmonaryPhysiologyandSleepMedicine,SirCharlesGairdnerHospital,
Perth,WA;7CentreforSleepScience,SchoolofAnatomy,PhysiologyandHumanBiology,UniversityofWesternAustralia,
Perth,WA;8DepartmentofThoracicMedicine,ConcordHospital,Sydney,NSW;9PhysiotherapyDepartment,RoyalPrince
AlfredHospital,Sydney,NSW,Australia;10PhysiotherapyDepartment,SingaporeGeneralHospital,Singapore
ABSTRACT
SUMMARY AT A GLANCE
Backgroundandobjective: In patientswith COPD, this
Ongoingfeedback(telephonecallsandbiofeedback)
study evaluated the effect on health-related quality of
was no more effective than no feedback during a
life(HRQoL)ofaddingongoingfeedbacktoa12-month
12-month unsupervised walking programme that
unsupervisedmaintenancewalkingprogramme.
Methods: Participants were randomized to either an followed a short-term supervised walking pro-
intervention group (IG) or control group (CG). Both gramme. Based on these findings, further research
groups completed the same 2-month supervised, walk- is needed to investigate the optimal design of unsu-
ing training programme followed by a 12-month unsu- pervised maintenance programmes in patients
pervised maintenance walking programme. During the withCOPD.
maintenanceprogramme,theIGreceivedongoingfeed-
back (telephone calls, biofeedback and progressivegoal
setting)andtheCGreceivednofeedback. Clinical trial registration:ACTRN12609000472279atwww.
Results: A total of 75 participants completed the study anzctr.org.au/
(mean (SD): age 69 (8) years; forced expiratory volume
in 1 s (FEV ) 43 (15) % predicted). There was no Key words: chronic obstructive pulmonary disease, exercise,
1
between-group differences in the magnitude of change health-relatedqualityoflife,maintenance,pulmonaryrehabilitation.
inHRQoLwhendatacollectedoncompletionofthe12-
month maintenance programme were compared with Abbreviations: 6MWD, 6-min walk distance; 6MWT, 6-min
thatcollectedeitherbeforethe2-monthsupervisedpro-
walktest;CG,controlgroup;CRQ,ChronicRespiratoryDisease
gramme (mean between-group difference (MD) in total Questionnaire;DL ,single-breathdiffusingcapacityofthelung
St George’s Respiratory Questionnaire change scores: forcarbonmonoxC idO e;ESWT,enduranceshuttlewalktest;FEV ,
1 point, 95% CI: −9 to 7) or on completion of the 2- forced expiratory volume in 1s; FVC, forced vital capacity1 ;
monthsupervisedprogramme(MD:4points,95%CI−2
HADS, Hospital Anxiety and Depression Scale; HRQoL, health-
to10). relatedqualityoflife;IG,interventiongroup;ISWT,incremental
Conclusion: Following a 2-month supervised walking shuttlewalktest;LMM,linearmixedmodel;MD,meanbetween-
training programme, ongoing feedback was no more groupdifference;PR,pulmonaryrehabilitation;RCT,randomized
effective than no feedback in maintaining HRQoL dur- controlled trial; RV, residual volume; SGRQ, St George’s
inga12-monthunsupervisedwalkingprogramme. RespiratoryQuestionnaire;TLC,totallungcapacity.
Correspondence: Sally L. Wootton, Chronic Disease INTRODUCTION
Community Rehabilitation Service, Northern Sydney Local
HealthDistrict,TheLodge,Building37,MacquarieHospital,Cnr In patients with chronic obstructive pulmonary disease
Twin and Badajoz Roads, North Ryde, Sydney, NSW 2113, (COPD), health-related quality of life (HRQoL) is signifi-
Australia.Email:sally.wootton@health.nsw.gov.au
cantly reduced compared with healthy individuals1 and
Received 15 March 2017; invited to revise 5 April 2017;
revised 24 May 2017; accepted 7 June 2017 (Associate Editor: betterHRQoLhasbeenrelatedtoreducedhospitaladmis-
MelissaJ.Benton). sions.2 Pulmonary rehabilitation (PR) has been shown to
©2017AsianPacificSocietyofRespirology Respirology(2017)
doi:10.1111/resp.13128
2 SLWoottonetal.
improveHRQoL3aswellasimproveexercisecapacityand differed once they entered the 12-month maintenance
reducehospitaladmissionsinpatientswithCOPD.4–6Fol- phase. Randomization was stratified according to lung
lowing completion of short-term (6–12weeks) PR pro- function (forced expiratory volume in 1 s (FEV ) < or
1
grammes, the positive effects on HRQoL and exercise ≥40% predicted), HRQoL measures using the St
capacity3 have been shown to decline within 1–2years.7–9 George’s Respiratory Questionnaire (SGRQ) (total score
Maintenance exercise programmes aim to encourage < or ≥45), exercise capacity (6-min walk distance
long-term adherence to exercise in order to preserve the (6MWD)<or≥70%predicted)andtrialcentre.
benefitsachievedduringshort-termprogrammes.Whilea Participants were recruited from outpatient PR pro-
recentsystematicreviewconcludedthatmaintenancepro- grammes in two cities within Australia between May
grammes with supervised exercise sessions, conducted at 2009 and June 2012. Inclusion and exclusion criteria
leastonceperweekcanmaintainexercisecapacityforup have been previously described.18 Written informed
to 6months in patients with COPD,10 many PR pro- consent was obtained from all participants. The study
grammes lack the capacity to offer long-term supervised was approved by the ethics committees of Sydney
maintenanceexerciseprogrammes.11–13 South West Area Health Service (Sydney, Australia),
Randomized controlled trials (RCT) investigating The University of Sydney (Sydney, Australia), Curtin
unsupervised maintenance programmes have shown University (Perth, Australia), Sir Charles Gairdner Hos-
little effect on maintaining HRQoL and exercise capac- pital (Nedlands, Australia) and Bentley Hospital (Perth,
ity, despite using strategies to encourage adherence Australia).
such as telephone support with or without monthly Following completion of the short-term supervised
supervised exercise sessions.7,14,15 When biofeedback programme, both the IG and CG were instructed to
strategies have been added to telephone support, perform unsupervised maintenance walking exercise,
maintenance of effects has been shown.16,17 However, 3 daysaweekfor12 months startingatthesamedura-
thesepreviousfindingsshouldbeinterpretedwithcau- tion achieved in the final week of supervised training
tion due to limitations arising from very small sample and at a pace which elicited a dyspnoea score of three
size17 and short durations of follow-up.16,17 As such, the to four on a modified 0–10 point category-ratio dys-
effectiveness of telephone support combined with bio- pnoea scale.19 In addition, the IG received telephone
feedback to maintain HRQoL and exercise capacity dur- calls, biofeedback provided via a pedometer (G-Sensor
ing an unsupervised maintenance walking programme accelerometer, Pedometers Australia, Cannington,
overalongertimeperiodremainsunknown. Australia) and progressive goal setting (based on
The primary aim of this study was to evaluate, in pedometerdata).Diarieswereprovidedforparticipants
patients with COPD, the effect on HRQoL of adding in both groups to record details of completed walking
ongoing feedback (telephone calls, biofeedback via sessions.Furtherdetailsoftheinterventionandthetel-
pedometer and progressive goal setting) compared ephone script can be found in Appendices S1 and S2
with no feedback during a 12-month unsupervised (SupplementaryInformation).
maintenance walking programme, which followed a
supervised walking training programme. The hypothe- Assessmentprotocolandmeasurements
sis was that, at study completion, participants who Participantswereassessedonfouroccasions overa14-
received the ongoing feedback would have better month period as follows: (i) prior to commencing the
HRQoL compared with those who did not receive the 2-month supervised walking training programme
ongoing feedback. The secondary aim of the study was (baseline assessment), (ii) at the end of the 2-month
toevaluatetheeffectsoftheongoingfeedbackonexer- supervised walking training programme which marked
cise capacity and adherence to the maintenance walk- the commencement of the maintenance phase (2-
ingprogramme. monthassessment),(iii)after6 monthsofmaintenance
(8-month assessment) and (iv) after 12 months of
maintenance (14-month assessment). During the base-
METHODS lineassessment,age,height,weight,gender,co-morbid
conditions and medication use were recorded. Levels
The study was a long-term, prospective, assessor- of anxiety and depression were measured by the Hos-
blinded, multicentre (five sites), RCT with concealed pitalAnxietyandDepressionScale(HADS).20Atallfour
allocation. Participants were randomized prior to com- assessment time points, participants completed mea-
mencing a 2-month supervised walking training pro- suresofHRQoL, exercise capacityandspirometriclung
gramme (i.e. baseline) via an independent telephone function over two visits within a 7-day period. FEV
1
randomization service using computerized random and forced vital capacity (FVC) were collected using a
number generator sequencing into two groups: an calibrated portable spirometer (EasyOne spirometer,
intervention group (IG) and a control group (CG). ndd Medical Technologies Inc., Andover, MA, USA)
Before commencing the 12-month maintenance pro- according tostandardprocedures.Lungvolumes(body
gramme,bothgroupsreceivedthesame2-monthinter- plethysmography) and single-breath diffusing capacity
vention of a supervised, walking training programme, of the lung for carbon monoxide (DL ) were meas-
CO
two to three times per week. The findings of the 2- ured at baseline only, according to standard protocols.
month study havebeenpreviouslyreported,comparing Measures obtained were compared with normative
the effects of supervised walking training (combined IG data.21–23 Disease severity was classified according to
and CG) to a group who received usual medical care the Global Strategy for the Diagnosis, Management,
and did not participate in any exercise training.18 The and Prevention of Chronic Obstructive Lung Disease
intervention for participants in the IG and CG only (GOLD)spirometriccriteria.24
©2017AsianPacificSocietyofRespirology Respirology(2017)
Feedbackduringmaintenanceexercise 3
Health-relatedqualityoflife Samplesizeanddataanalysis
The primary outcome was HRQoL measured by the The sample size was based on detection of a clinical
SGRQ.25 The interviewer-administered Chronic Respi- meaningful difference in total SGRQ score between the
ratory Disease Questionnaire (CRQ), with the indivi- IG and CG at the 14-month assessment. Eighty-six par-
dualizeddyspnoeadomain,wasalsocompleted.26 ticipantsweresufficienttoprovide80%powertodetect
a between-group difference in SGRQ total score of at
least 7.7 points, which is greater than the minimum
Exercisecapacity clinically important difference (α = 0.05, two-sided).28
This assumed an SD of 12.7 points in total SGRQ score
Functional exercise capacity was measured by the 6-
as previously reported.29 To allow for a 10% dropout,
min walk test (6MWT), peak exercise capacity by the
95 participants were required. Data were analysed
incremental shuttle walk test (ISWT) and endurance
using SPSS software (Version 20 for Windows,IBM Inc,
exercise capacity by the endurance shuttle walk test
Armonk, NY, USA). Intention to treat analysis was con-
(ESWT).27 Procedures for the walk tests have been pre-
ducted with no imputation of missing data. Descriptive
viouslydescribed.18
statistics are presented as raw mean values and SD
unless otherwise stated. Linear mixed models (LMM)
were used to determine significance between groups
Adherencetounsupervisedmaintenance across all time points using thesample that was availa-
walkingprogramme ble ateach time point. An estimate of the within-group
Adherence in both groups was determined using data effect on three comparisons, baseline to 2 months;
from diaries and also, for the IG, by reviewing tele- baseline to 14 months; and 2 to 14 months, was deter-
phone transcripts. At the 8-month and 14-month mined for each group using the least significant differ-
assessments, the number of returned diaries in both ence (pairwise comparison) and is reported as mean
groups was recorded, as well as the number of com- differences and 95% CI from the predicted values of
pletedtelephonetranscriptsintheIG. the LMM. To evaluate the between-group treatment
Assessed for eligibility: n = 399
Excluded: n = 256
Did not meet inclusion criteria (188)
Declined to participate (66)
Other reasons (2)
Randomized: n = 95 Allocated to the Usual Care Group of
the precursor of this study (48)
Allocated to IG: n = 49 Allocated to CG: n = 46
Baseline assessment Baseline assessment
2 months supervised short-term walking training
Start of maintenance study
M Wis its hi dn rg a wda nt fa r: o mn = s t5 u d y (2) n = 4 4 n = 3 8 M Wis its hi dn rg a wda nt fa r: o mn = s t8 u dy (2)
DNA for assessment (3) 2-month assessment 2-month assessment DNAforassessment(6)
Missing data: n = 6 n = 4 1 n = 3 9 Missing data: n = 5
Withdrawn from study (3) 8-month assessment 8-month assessment DNA for assessment (5)
DNA for assessment (3)
Missing data: n = 9
Missing data: n = 4 n = 4 0 n = 3 5 Withdrawn from study (1)
DNA for assessment (4) 14-month assessment 14-month assessment Deceased (1)
DNA for assessment (7)
Figure1 Participantflow.Numbersateachtimepointarebasedonthosethatenteredthemaintenancephaseofthestudy.Insome
instances, participants may not have attended the 2- or 8-month assessment but attended the 14-month assessment. CG, control
group;IG,interventiongroup.
Respirology(2017) ©2017AsianPacificSocietyofRespirology
4 SLWoottonetal.
effect on these three comparisons, change scores were Table1 Participantcharacteristics
determined by simple subtraction of the within-group
effect and differences in the change scores were com- IG CG
paredusingindependentt-tests. Variable n=49 n=46
Age(years) 70(7) 69(9)
RESULTS Gender,male/female 25/24 30/16
Height(m) 1.7(0.1) 1.7(0.1)
Participantflowis presentedinFigure 1.Baseline charac- Weight(kg) 69(16) 74(14)
teristics of participants were similar between groups BMI(kg/m2) 24(5) 26(5)
(Table 1). Participants had moderate to severe COPD Currentsmokers,n(%) 9(18) 6(13)
(FEV : 45 (15) % predicted),24 reduced HRQoL (SGRQ Anxiety,HADSscore 6(4) 7(4)
1
total score: 46 (17)), reduced exercise capacity (6MWD: Depression,HADSscore 5(4) 5(3)
74 (13) % predicted) and symptoms of anxiety and Pulmonaryfunction
depression that were within normal range (0–7 points on FEV 1(L) 1.08(0.37) 1.18(0.46)
HADS20). Participants completed an average of 17 (7) out FEV 1(%predicted) 43(15) 43(15)
ofapossible24supervisedwalkingtrainingsessionsprior FVC(L) 2.60(0.72) 2.82(0.95)
to commencement of the maintenance programme. Of FVC(%predicted) 75(16) 76(19)
the 95 participants who commenced the 2-month super- FEV 1/FVC(%) 43(13) 43(14)
vised walking training programme, 20 participants (21%) TLC(%predicted) 114(33) 110(17)
didnotcompleteanyofthe14-monthoutcomemeasures. FRC(%predicted) 148(60) 139(34)
Noadverseeventswerereportedduringthestudy. RV(%predicted) 157(76) 142(40)
RV/TLC(%) 53(9) 50(10)
DL (%predicted) 43(16) 45(17)
CO
Health-relatedqualityoflife GOLDgrade
The SGRQ outcomes are presented in Tables 2–4 and II,n(%) 23(47) 17(37)
Figure 2A. Both the IG and CG significantly improved III,n(%) 18(37) 24(52)
SGRQ total score at the end of the 2-month supervised IV,n(%) 8(16) 5(11)
walking training programme. Between-group analyses Respiratorymedication
demonstrated no significant differences in the change Short-actingbronchodilator,n(%) 28(57) 27(59)
in SGRQ from baseline to 14 months or from 2 to Long-actingbronchodilator,n(%) 31(63) 30(65)
14 months(Fig. 2A).TheresultsfromtheCRQarepre- Inhaledcorticosteroid,n(%) 2(4) 3(7)
sentedinTablesS1–S3(SupplementaryInformation). Combinationtherapy,n(%) 31(63) 31(67)
Oralcorticosteroid,n(%) 6(12) 8(17)
Co-morbidity
Exercisecapacity
Hypertension,n(%) 22(45) 18(39)
The exercise capacity outcomes are presented in Cardiac(includingprevious 19(39) 17(37)
Tables 2–4 and Figure 2B. Both the IG and CG signifi- surgery),n(%)
cantlyimprovedexercisecapacitymeasuredbytheESWT Diabetes,n(%) 1(2) 3(7)
withtheIGalsosignificantlyimprovingontheISWTand
Asthma,n(%) 7(14) 6(13)
6MWTattheendofthe2-monthsupervisedwalkingpro- Bronchiectasis,n(%) 1(2) 0(0)
gramme. Between-group analyses demonstrated no sig- Otherrespiratoryhistory,n(%) 4(8) 5(11)
nificant differences in change in exercise capacity from Cancer,n(%) 3(6) 4(9)
baselineto14monthsorfrom2to14 months. Non-cardiacsurgery,n(%) 5(10) 5(11)
Neurological,n(%) 0(0) 1(2)
Psychological,n(%) 7(14) 8(17)
Adherencetounsupervisedmaintenance
Increasedcholesterol,n(%) 9(18) 10(22)
walkingprogramme
Musculoskeletal,n(%) 21(43) 18(39)
Reported levels of adherence to unsupervised mainte- Other,n(%) 29(59) 34(74
nance walking exercise sessions are presented in
Table S4 (Supplementary Information). Between-group Datapresentedasmean(SD)unlessstatedotherwise.
analyses of adherence levels were not possible due to CG, control group; DL , single-breath diffusing capacity of the
CO
lackofdataintheCG. lung for carbon monoxide; FEV 1, forced expiratory volume in 1s;
FRC,functionalresidual capacity;FVC, forcedvital capacity;GOLD,
GlobalStrategyfortheDiagnosis,Management,andPreventionof
DISCUSSION Chronic Obstructive Lung Disease; HADS, Hospital Anxiety and
Depression Scale; IG, intervention group; n, number; RV, residual
Thislarge,multicentre,RCTwasdesignedtodetermine volume;TLC,totallungcapacity.
the effects on HRQoL of adding ongoing feedback to a
12-month unsupervised maintenance walking pro- significantbetween-group differences inthe magnitude
gramme that followed a 2-month, supervised, walking of change in HRQoL or in any of the secondary out-
training programme in patients with COPD. Although comes between baseline and 14 months or between
the supervised programme produced significant 2and14 months.
improvements in HRQoL in both groups, when all Our finding of no between-group differences in
assessmenttimepointswereconsidered,therewereno HRQoL is consistent with a previous RCT that showed
©2017AsianPacificSocietyofRespirology Respirology(2017)
Feedbackduringmaintenanceexercise 5
Table2 Health-relatedqualityoflifeandexercisecapacityatbaseline,2-,8-and14-monthassessment
Baseline 2-Month 8-Month 14-Month
assessment assessment assessment assessment LMM
P-value
IG CG IG CG IG CG IG CG Time×group
SGRQ,n 49 46 43 37 41 38 38 33
Totalscore 46(18) 47(16) 40(12) 42(16) 40(15) 45(18) 40(17) 47(17) 0.71
Symptoms 57(22) 55(22) 49(22) 52(25) 48(22) 54(27) 48(24) 52(24) 0.66
Activity 62(20) 66(19) 57(18) 61(19) 61(19) 63(20) 60(22) 66(19) 0.53
Impacts 32(17) 35(19) 27(13) 28(16) 25(15) 32(18) 26(16) 35(19) 0.29
6MWT,n 49 46 42 35 38 36 35 27
Distance(m) 458(87) 467(80) 479(86) 468(100) 464(105) 453(93) 469(98) 432(121) 0.11
ISWT,n 49 46 41 33 37 36 28 35
Distance(m) 315(107) 317(112) 361(125) 323(140) 346(123) 328(134) 338(135) 324(143) 0.25
ESWT,n 49 46 43 35 37 36 29 35
Time(s) 304(210) 317(186) 584(388) 561(395) 529(387) 443(360) 495(383) 405(377) 0.41
Datapresentedasrawmean(SD).
6MWT, 6-minwalktest;CG,controlgroup;ESWT,enduranceshuttlewalktest;IG,interventiongroup;ISWT,incrementalshuttle
walktest;LMM,linearmixedmodel;n,numberofparticipantsanalysed;SGRQ,StGeorge’sRespiratoryQuestionnaire.
Table3 Health-relatedqualityoflifeandexercisecapacitywithin-groupdifferences
Meandifference Meandifference Meandifference
2months−baseline 14months−baseline 14months−2months
IG CG IG CG IG CG
n 49 46 49 46 49 46
SGRQ
Totalscore −6(−10,−2)* −6(−10,−2)* −5(−9,−1)* −2(−6,2) 1(−2,5) 4(0.1,8)*
Symptoms −8(−14,−1)* −3(−10,4) −7(−15,1) −4(−12,4) 0(−7,8) −1(−9,8)
Activity −4(−8,0) −5(−10,−1)* 0(−4,5) 0(−4,5) 4(−1,9) 6(1,11)*
Impacts −5(−9,−1)* −7(−12,−3)* −5(−10,−1)* −3(−7,2) −0.5(−4,3) 4(1,8)*
6MWT Distance(m) 17(4,30)* −1(15,−13) −6(−26,13) −40(−61,−18) −23(−41,−5)* −39(−59,−18)*
ISWT Distance(m) 36(17,55)* 8(−14,29) −1(−20,17) −1(−21,20) −37(−60,−14)* −8(−34,17)
ESWT Time(s) 256(161,351)* 214(110,318)* 146(43,249)* 46(−67,159) −110(−232,12) −168(−303,−33)*
*P<0.05.
Datapresentedaspredictedbetween-timemean(95%CI)differencesbygroup.
6MWT, 6-minwalktest;CG,controlgroup;ESWT,enduranceshuttlewalktest;IG,interventiongroup;ISWT,incrementalshuttle
walktest;n,numberofparticipantsanalysed;SGRQ,StGeorge’sRespiratoryQuestionnaire.
no difference between groups in the SGRQ during a had a significant decline in ESWT time from 2 to
12-month unsupervised maintenance exercise pro- 14 months and this had returned to baseline levels by
gramme despite the IG receiving monthly supervised theend ofthestudy, demonstrating nomaintenanceof
sessions.7 However, some evidence of the effectiveness endurance walking capacity in this group. There were,
oftheongoingfeedbackintheIGwasdemonstratedby however, no between-group differences in ESWT time
SGRQ total score being maintained from 2 to when changes from baseline to 14 months or 2 to
14 months and remaining significantly better than 14 months were compared. This finding is in contrast
baseline in the IG by the end of the study. In contrast, to previous RCTs or studies that demonstrated mainte-
intheCG,therewasasignificantdeclineinSGRQtotal nance of functional exercise capacity during unsuper-
score from 2 to 14 months and this had returned to vised maintenance walking programmes that
baselinelevelsbytheendofthestudy. investigated a similar combination of telephone sup-
The ESWT is an outcome which represents endur- port with biofeedback.16,17 However, these previous
ance walking capacity and is particularly sensitive to studies were limited by lack of blinded assessment,16
the effects of short-term training in COPD.27 Both small sample size17 and short follow-up periods of 316
groupshadsignificantimprovementsinESWTtimefol- and617months.Inaddition,participantsintheseprevi-
lowing the short-term training. In the IG, there was a ous studies16,17 were randomized following completion
non-significant decline in ESWT time from 2 to of short-term PR whereas in our study, randomization
14 months which remained significantly better at occurred at commencement of the supervised walking
14 monthscomparedwithbaseline.Incontrast,theCG training. Participants who complete PR may be more
Respirology(2017) ©2017AsianPacificSocietyofRespirology
Table4 Health-relatedqualityoflifeandexercise
capacitybetween-groupdifferences
Between-groupdifference
inchangescores
Between Between
baselineand 2-monthand
14-month 14-month
assessment assessment
(95%CI) (95%CI)
SGRQ n 71 68
Total 2(−4,8) 4(−2,9)
score 700
Symptoms 2(−10,14) −0.9(−13,11)
600
Activity −1(−8,5) 3(−4,10)
Impacts 1(−6,7) 6(0.4,12) 500
6MWT n 62 60 400
Distance(m) −37(−69,−4) −16(−46,15)
300
ISWT n 63 59
Distance(m) 2(−27,32) 23(−13,60) 200
ESWT n 64 62 100
Time(s) −96(−253,61) −54(−245,137) 0 (baseline) 2 8 14
Data was determined from the predicted means from Linear
MixedModel(LMM).ESWT:enduranceshuttlewalktest;ISWT:
incremental shuttle walk test; m: metres; n: number of partici-
pants analysed; s: seconds; SGRQ: St George’s Respiratory
Questionnaire;6MWT:six-minutewalktest
compliant with exercise and be more motivatedtopar-
ticipate in long-term exercise training, which could
have contributed to the positive effects on exercise
capacity.16,17 We chose to randomize participants prior
to commencing a short-term PR programme as this is
more representative of the patient population and
patientjourney. adherence of 52% to the prescribed walking exercise
While HRQoL and ESWT were maintained in the IG, frequencyduringthemaintenancephasewassimilarto
this did not translate into between-group differences that reported in other studies7,31,32 and may be a more
which may have been a consequence of a number of accurate reflection of adherence levels in patients with
factors, in particular, that the changes were small in COPDthanthatcollectedviadiaries.Afurtherexplana-
relation to the variability in measurements. The small tion for the lack of between-group difference may be
effect of the intervention may have resulted from the thatbothgroupswereinstructedtodowalkingexercise
relatively poor adherence to the unsupervised walking during the maintenance programme, thus potentially
programme, which was somewhat surprising as we reducing the between-group differences. This contrasts
hypothesized that the regular feedback and ongoing withapreviousmaintenancestudy17inwhichthecom-
support using health coaching principles30 would have parisongroupdidnotdomaintenanceexerciseandthe
resulted in improved adherence during the mainte- use of telephone calls and pedometers was effective at
nance phase. It appears from our findings that this producing between-group differences in HRQoL at
level of support was not sufficient or appropriately tar- 6 months following completion of the initial training
geted to change exercise behaviour and encourage programme, mainly due to a decline in HRQoL in
adherence in patients with COPD in order to maintain theCG.17
a significantly greater HRQoL and exercise capacity A limitation of the study was the relatively large loss
than those not receiving such interventions. Adherence to follow-up (21%) during the maintenance phase
remainsdifficulttoobjectivelymeasureandhenceself- which meantthatthetarget of86participantscomplet-
reported diaries are often used; however, our results ing the study was not reached. This dropout rate is
demonstratedlimitedengagementintheuseofdiaries. consistent with other maintenance studies in
While adherence levels in the CG appeared to be COPD.7,15,17,33 A larger sample size would have been
higher than in the IG, this only reflected the low num- unlikely to change the between-group differences as
ber of diaries returned in the CG rather than greater
theP-valueswerenotclosetobeingsignificantandthe
adherence. A greater amount of data was available on magnitude of the differences were less than the mini-
thelevelofadherenceintheIGduetoinformationcol- mum clinically important differences so unlikely to be
lected during the regular telephone calls. The IG important. A second limitation of the study was that a
)s(
emiT
55
50
45
40
35
30
0 (baseline) 2 8 14
(B)
†
§ ‡
Time (months)
erocs
latoT
6 SLWoottonetal.
(A)
§
‡
†
Time (months)
Figure2 (A)StGeorge’sRespiratoryQuestionnairetotalscore.
Dataarepresentedaspredictedmeanvaluesfromlinearmixed
models (LMM) with error bars representing SE. (B) Endurance
shuttle walktest(ESWT).Dataarepresentedasadjustedmean
valuesfromLMMwitherrorbarsrepresentingSE.(AandB) ,
intervention group (IG); , control group (CG); †IG significant
improvementfrombaselineto2months;‡IGsignificantimprove-
mentfrombaselineto14months;§CGsignificantimprovement
frombaselineto2months.
©2017AsianPacificSocietyofRespirology Respirology(2017)
Feedbackduringmaintenanceexercise 7
per-protocol analysis was not possible as there were 6 RubíMD,RenomF,RamisF,MedinasM,CentenoMJ,GórrizM,
insufficient data to determine accurate adherence to CrespíE,MartínB,SorianoJB.Effectivenessofpulmonaryrehabil-
the maintenance walking programme, due to the itationinreducinghealthresourcesuseinchronicobstructivepul-
inadequacies of diary use. In future studies, more
monarydisease.Arch.Phys.Med.Rehabil.2010;91:364–8.
objective measures of adherence would help inform 7 BrooksD,KripB,Mangovski-AlzamoraS,GoldsteinRS.Theeffect
ofpostrehabilitationprogrammesamongindividualswithchronic
clinicians aboutthetrueeffectofunsupervisedmainte-
obstructivepulmonarydisease.Eur.Respir.J.2002;20:20–9.
nance interventions in adherent participants. Despite
8 FoglioK,BinachiL,BrulettiG,BattistaL,PaganiM,AmbrosinoN.
these limitations, the strength of this study was the
Long-termeffectivenessofpulmonaryrehabilitationinpatientwith
robust methodological design using intention-to-treat chronicairwayobstruction.Eur.Respir.J.1999;13:125–32.
analysis with participants recruited prior to short-term
9 Troosters T, Gosselink R, Decramer M. Short- and long-term
supervised exercise training, thus reflecting real-life effectsofoutpatientrehabilitationinpatientswithchronicobstruc-
clinicalpractice. tivepulmonarydisease:arandomizedtrial.Am.J.Med.2000;109:
In conclusion, this study investigated the effects on 207–12.
HRQoL of adding ongoing feedback to a 12-month 10 Beauchamp MK, Evans R, Janaudis-Ferreira T, Goldstein RS,
unsupervised maintenance walking programme that BrooksD.Systematicreviewofsupervisedexerciseprogramsafter
followed a 2-month supervised walking training pro- pulmonary rehabilitation in individuals with COPD. Chest 2013;
gramme in patients with COPD. There were no
144:1124–33.
11 Steiner M, Holzhauer-Barrie J, Lowe D, Searle L, Skipper E,
between-group differences in the magnitude of change
Welham S, Roberts CM. Pulmonary rehabilitation: time to breath
in HRQoL from baseline to 14 months or from 2 to
better. National Chronic Obstructive Pulmonary Disease (COPD)
14 months. Based on these findings, ongoing feedback
Audit Programme: Resources and organisation of Pulmonary
was no more effective than no feedback in maintaining Rehabilitation services in England and Wales, 2015. Accessed
thegainsofshort-termsupervisedwalkingprogramme. [12 Dec 2015.] Available from URL: http://www.hqip.org.uk/
As long-term supervised maintenance exercise pro- resources/copd-audit-organisational-report-2015/
grammes are not always an option following PR, fur- 12 Camp PG, Hernandez P, Bourbeau J, Kirkham A, Debigare R,
ther research is needed to investigate the optimal Stickland MK, Goodridge D, Marciniuk DD, Road JD, Bhutani M
design of unsupervised maintenance programmes in
etal.PulmonaryrehabilitationinCanada:areportfromtheCana-
patientswithCOPD. dian Thoracic Society COPD Clinical Assembly. Can. Respir. J.
2015;22:147–52.
13 AustralianInstituteofHealthandWelfare.Monitoringpulmonary
Acknowledgements rehabilitation and long-term oxygen therapy for people with
chronic obstructive pulmonary disease (COPD), 2013. [Accessed
TheauthorswouldliketothankthestaffatRoyalPrinceAlfred
18Nov2014.]AvailablefromURL:www.aihw.gov.au
Hospital,ConcordRepatriationGeneralHospital,PrinceofWales
14 RiesAL,KaplanRM,MyersR,PrewittLM.Maintenanceafterpul-
Hospital, Manly Hospital, Hornsby Ku-ring-gai Hospital, Bentley
monaryrehabilitationinchroniclungdisease.Am.J.Respir.Crit.
Hospital and Sir Charles Gairdner Hospital for their assistance
CareMed.2003;167:880–8.
andsupport,andalsothankthepatientswhoparticipatedinthe
15 Waterhouse JC, Walters SJ, Oluboyede Y, Lawson RA. A rando-
study and Professor Jennifer Peat for statistical support. The
mised2X2trialofcommunityversushospitalpulmonaryrehabili-
studywasfundedbyanAustralianNationalHealthandMedical
tation, followed by telephone or conventional follow-up. Health
ResearchCouncilprojectgrant:570814.P.R.E.wasfundedbya
Technol.Assess.2010;14:1–140.
National Health and Medical Research Council of Australia
16 Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S,
(NHMRC)SeniorResearchFellowship(1042341).
HowardJ,HaselkornJK.Arandomizedclinicaltrialofanactivity
andexerciseadherenceinterventioninchronicpulmonarydisease.
Disclosure statement
Arch.Phys.Med.Rehabil.2008;89:404–12.
This study was previously presented at the Australian Physio- 17 Du Moulin M, Taube K, Wegscheider K, Behnke M, van den
therapy Association Cardiorespiratory Physiotherapy Australia Bussche H. Home-based exercise training as maintenance after
14th Biennial Scientific Conference in 2015 and the TSANZSRS outpatientpulmonaryrehabilitation.Respiration2009;77:139–45.
AnnualScientificMeetingin2017. 18 WoottonSL,NgC,McKeoughZJ,JenkinsS,HillK,EastwoodPR,
HillmanDR,CecinsN,SpencerLM,JenkinsCetal.Groundbased
walking training improves quality of life and exercise capacity in
REFERENCES COPD.Eur.Respir.J.2014;44:885–94.
19 Borg G. Psychophysical bases of perceived exertion. Med. Sci.
1 Ilgin D,Ozalevli S, KilincO, Sevinc C, Cimrin AH, UcanES.Gait SportsExerc.1982;14:377–81.
speed as a functional capacity indicator in patients with chronic 20 ZigmondAS,SnaithRP.Thehospitalanxietyanddepressionscale.
obstructivepulmonarydisease.Ann.Thorac.Med.2011;6:141–6. ActaPsychiatr.Scand.1983;67:361–70.
2 OsmanLM,GoddenDJ,FriendJAR,LeggeJS,DouglasJG.Quality 21 Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference
oflifeandhospitalre-admissioninpatientswithchronicobstruc- valuesfromasampleofthegeneralUSpopulation.Am.J.Respir.
tivepulmonarydisease.Thorax1997;52:67–71. Crit.CareMed.1999;159:179–87.
3 SpruitMA,SinghSJ,GarveyC,ZuWallackR,NiciL,RochesterC, 22 Stocks J, Quanjer P. Reference values for residual volume, func-
HillK,HollandAE,LareauSC,ManWDCetal.AnOfficialAmeri- tionalresidualcapacityandtotallungcapacity.Eur.Respir.J.1995;
can Thoracic Society / European Respiratory Society statement: 8:492–506.
key concepts and advances in pulmonary rehabilitation. Am. 23 Crapo RO, Morris AH. Standardised single breath normal values
J.Respir.Crit.CareMed.2013;188:e13–64. forcarbonmonoxidediffusingcapacity.Am.Rev.Resp.Dis.1981;
4 CecinsN,GeelhoedE,JenkinsS.Reductioninhospitalisationsfol- 123:185–9.
lowing pulmonary rehabilitation in patient with COPD. Aust. 24 Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ,
HealthRev.2008;32:415–22. BourbeauJ,CelliBR,ChenR,DecramerM,FabbriLMetal.Global
5 Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost Strategy for the Diagnosis, Management, and Prevention of
effectivenessofanoutpatientmulitdisciplinarypulmonaryrehabil- Chronic Obstructive Lung Disease 2017 Report: GOLD Executive
itationprogramme.Thorax2001;56:779–84. Summary.Arch.Bronconeumol.2017;53:128–49.
Respirology(2017) ©2017AsianPacificSocietyofRespirology
8 SLWoottonetal.
25 JonesPW,QuirkFH,BaveystockCM.TheStGeorge’sRespiratory 32 HeppnerPS,MorganC,KaplanRM,RiesAL.Regularwalkingand
Questionnaire(SGRQ).Respir.Med.1991;85:25–31. long-term maintenance of outcomes after pulmonary rehabilita-
26 GuyattGH,BermanLB,TownsendM,PugsleySO,ChambersLW. tion.J.Cardiopulm.Rehabil.2006;26:44–53.
A measure of quality of life for clinicaltrials in chronic lung dis- 33 Spencer L, Alison J, McKeough Z. Maintaining benefits following
ease.Thorax1987;42:773–8. pulmonary rehabilitation: a randomised controlled trial. Eur.
27 HollandAE,SpruitMA,TroostersT,PuhanMA,PepinV,SaeyD, Respir.J.2010;35:571–7.
McCormack MC, Carlin BW, Sciurba FC, Pitta F et al. An official
EuropeanRespiratorySociety/AmericanThoracicSocietytechnical
standard: field walking tests in chronic respiratory disease. Eur. SupplementaryInformation
Respir.J.2014;44:1429–46. Additional supplementary information can be accessed via the
28 JonesPW.Interpretingthresholdsforaclinicallysignificantchange htmlversionofthisarticleatthepublisher’swebsite.
in health status in asthma and COPD. Eur. Respir. J. 2002; 19:
398–404. Appendix S1 Further details of intervention: interven-
29 Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, tiongroup.
ShielsK,TunbridgeJ,Turner-LawlorPJ,PayneN,NewcombeRG AppendixS2Telephonescript.
et al. Results at 1 year of outpatient multidisciplinary pulmonary Table S1 Chronic Respiratory Disease Questionnaire at
rehabilitation: a randomised controlled trial. Lancet 2000; 355: baseline,2-,8-and14-monthassessment.
362–8.
Table S2 Chronic Respiratory Disease Questionnaire
30 HealthChangeAustralia.ModelofHealthChange.[Accessed20Jan differencewithingroups.
2016.]AvailablefromURL:www.healthchangeassociates.com
Table S3 Chronic Respiratory Disease Questionnaire
31 Carrieri-Kohlman V, Nguyen HQ, Donesky-Cuenco D, Demir-
between-groupdifferences.
Deviren S, Neuhaus J, Stulbarg MS. Impact of brief or extended
exercisetrainingonthebenefitofadyspneaself-managementpro- Table S4 Reported adherence to walking training dur-
graminCOPD.J.Cardiopulm.Rehabil.2005;25:275–84. ingthe12-monthmaintenancewalkingprogramme.
©2017AsianPacificSocietyofRespirology Respirology(2017)
